Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
66.76 USD | +0.91% | -1.92% | -17.59% |
Apr. 19 | Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says | MT |
Apr. 19 | BMO Capital Adjusts Price Target on Gilead Sciences to $80 From $89 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.59% | 83.25B | |
+24.60% | 654B | |
+24.08% | 552B | |
-5.63% | 356B | |
+15.37% | 319B | |
+7.38% | 295B | |
+3.26% | 211B | |
+0.78% | 206B | |
-9.69% | 147B | |
-6.63% | 144B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Gilead Sciences Shares Spike Premarket, Trodelvy 'Significantly' Improves Overall Survival